129 related articles for article (PubMed ID: 15262417)
1. Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates.
Gittens SA; Bagnall K; Matyas JR; Löbenberg R; Uludag H
J Control Release; 2004 Aug; 98(2):255-68. PubMed ID: 15262417
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate conjugation to proteins as a means to impart bone affinity.
Uludag H; Kousinioris N; Gao T; Kantoci D
Biotechnol Prog; 2000; 16(2):258-67. PubMed ID: 10753453
[TBL] [Abstract][Full Text] [Related]
3. Imparting mineral affinity to fetuin by bisphosphonate conjugation: a comparison of three bisphosphonate conjugation schemes.
Gittens SA; Bansal G; Kucharski C; Borden M; Uludag H
Mol Pharm; 2005; 2(5):392-406. PubMed ID: 16196492
[TBL] [Abstract][Full Text] [Related]
4. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite.
Zhang S; Wright JE; Ozber N; Uludağ H
Macromol Biosci; 2007 May; 7(5):656-70. PubMed ID: 17457941
[TBL] [Abstract][Full Text] [Related]
5. Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates.
Gittens SA; Matyas JR; Zernicke RF; Uludağ H
Pharm Res; 2003 Jul; 20(7):978-87. PubMed ID: 12880282
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of disulfide-linked fetuin-bisphosphonate conjugates with three physiological thiols.
Zhang S; Wright JE; Bansal G; Cho P; Uludag H
Biomacromolecules; 2005; 6(5):2800-8. PubMed ID: 16153121
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
8. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.
Lin H; Zhao Y; Sun W; Chen B; Zhang J; Zhao W; Xiao Z; Dai J
Biomaterials; 2008 Mar; 29(9):1189-97. PubMed ID: 18083224
[TBL] [Abstract][Full Text] [Related]
9. Targeting systemically administered proteins to bone by bisphosphonate conjugation.
Uludag H; Yang J
Biotechnol Prog; 2002; 18(3):604-11. PubMed ID: 12052079
[TBL] [Abstract][Full Text] [Related]
10. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2).
Liu LS; Ng CK; Thompson AY; Poser JW; Spiro RC
J Biomed Mater Res; 2002 Oct; 62(1):128-35. PubMed ID: 12124794
[TBL] [Abstract][Full Text] [Related]
12. A comparison of mineral affinity of bisphosphonate-protein conjugates constructed with disulfide and thioether linkages.
Wright JE; Gittens SA; Bansal G; Kitov PI; Sindrey D; Kucharski C; Uludağ H
Biomaterials; 2006 Feb; 27(5):769-84. PubMed ID: 16055182
[TBL] [Abstract][Full Text] [Related]
13. Imparting mineral affinity to proteins with thiol-labile disulfide linkages.
Bansal G; Wright JE; Zhang S; Zernicke RF; Uludag H
J Biomed Mater Res A; 2005 Sep; 74(4):618-28. PubMed ID: 16037953
[TBL] [Abstract][Full Text] [Related]
14. Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates.
Gittens SA; Kitov PI; Matyas JR; Löbenberg R; Uludağ H
Pharm Res; 2004 Apr; 21(4):608-16. PubMed ID: 15139517
[TBL] [Abstract][Full Text] [Related]
15. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments.
Varkey M; Kucharski C; Haque T; Sebald W; Uludağ H
Clin Orthop Relat Res; 2006 Feb; 443():113-23. PubMed ID: 16462434
[TBL] [Abstract][Full Text] [Related]
16. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.
Fu YC; Nie H; Ho ML; Wang CK; Wang CH
Biotechnol Bioeng; 2008 Mar; 99(4):996-1006. PubMed ID: 17879301
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery.
Nie H; Soh BW; Fu YC; Wang CH
Biotechnol Bioeng; 2008 Jan; 99(1):223-34. PubMed ID: 17570710
[TBL] [Abstract][Full Text] [Related]
18. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2).
Na K; Kim SW; Sun BK; Woo DG; Yang HN; Chung HM; Park KH
Biomaterials; 2007 Jun; 28(16):2631-7. PubMed ID: 17331575
[TBL] [Abstract][Full Text] [Related]
19. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.
Fakhry A; Ratisoontorn C; Vedhachalam C; Salhab I; Koyama E; Leboy P; Pacifici M; Kirschner RE; Nah HD
Bone; 2005 Feb; 36(2):254-66. PubMed ID: 15780951
[TBL] [Abstract][Full Text] [Related]
20. Bone affinity of a bisphosphonate-conjugated protein in vivo.
Uludag H; Gao T; Wohl GR; Kantoci D; Zernicke RF
Biotechnol Prog; 2000; 16(6):1115-8. PubMed ID: 11101342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]